vs
Side-by-side financial comparison of CG Oncology, Inc. (CGON) and QMMM Holdings Ltd (QMMM). Click either name above to swap in a different company.
CG Oncology, Inc. is the larger business by last-quarter revenue ($2.3M vs $2.0M, roughly 1.1× QMMM Holdings Ltd). QMMM Holdings Ltd runs the higher net margin — -7.1% vs -1779.0%, a 1771.9% gap on every dollar of revenue.
CG Oncology, Inc. is a clinical-stage biotechnology company focused on developing innovative targeted immunotherapies for urological cancers including non-muscle invasive bladder cancer. It primarily operates in the U.S. market, advancing pipeline candidates to address unmet medical needs for patients with limited treatment options.
CGON vs QMMM — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.3M | $2.0M |
| Net Profit | $-41.3M | $-146.1K |
| Gross Margin | — | 27.1% |
| Operating Margin | -2097.3% | -6.5% |
| Net Margin | -1779.0% | -7.1% |
| Revenue YoY | 409.2% | — |
| Net Profit YoY | -29.9% | — |
| EPS (diluted) | $-0.52 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.3M | — | ||
| Q3 25 | $1.7M | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | $2.0M | ||
| Q4 24 | $456.0K | — | ||
| Q1 24 | $529.0K | $1.3M |
| Q4 25 | $-41.3M | — | ||
| Q3 25 | $-43.8M | — | ||
| Q2 25 | $-41.4M | — | ||
| Q1 25 | — | $-146.1K | ||
| Q4 24 | $-31.8M | — | ||
| Q1 24 | $-16.9M | $-612.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 27.1% | ||
| Q4 24 | — | — | ||
| Q1 24 | — | 24.1% |
| Q4 25 | -2097.3% | — | ||
| Q3 25 | -3069.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6.5% | ||
| Q4 24 | -8344.1% | — | ||
| Q1 24 | -4247.4% | -46.2% |
| Q4 25 | -1779.0% | — | ||
| Q3 25 | -2629.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -7.1% | ||
| Q4 24 | -6973.7% | — | ||
| Q1 24 | -3200.8% | -45.5% |
| Q4 25 | $-0.52 | — | ||
| Q3 25 | $-0.57 | — | ||
| Q2 25 | $-0.54 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-0.47 | — | ||
| Q1 24 | $-0.36 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $742.2M | $167.9K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $752.6M | $3.9M |
| Total Assets | $791.6M | $4.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $742.2M | — | ||
| Q3 25 | $680.3M | — | ||
| Q2 25 | $661.1M | — | ||
| Q1 25 | — | $167.9K | ||
| Q4 24 | $742.0M | — | ||
| Q1 24 | $566.5M | $218.9K |
| Q4 25 | $752.6M | — | ||
| Q3 25 | $687.6M | — | ||
| Q2 25 | $670.4M | — | ||
| Q1 25 | — | $3.9M | ||
| Q4 24 | $733.4M | — | ||
| Q1 24 | $568.9M | $-1.1M |
| Q4 25 | $791.6M | — | ||
| Q3 25 | $729.9M | — | ||
| Q2 25 | $701.4M | — | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | $754.8M | — | ||
| Q1 24 | $579.1M | $1.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-36.2M | $-301.2K |
| Free Cash FlowOCF − Capex | $-36.2M | — |
| FCF MarginFCF / Revenue | -1560.0% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-124.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-36.2M | — | ||
| Q3 25 | $-38.9M | — | ||
| Q2 25 | $-28.0M | — | ||
| Q1 25 | — | $-301.2K | ||
| Q4 24 | $-20.7M | — | ||
| Q1 24 | $-26.0M | $-184.6K |
| Q4 25 | $-36.2M | — | ||
| Q3 25 | $-39.0M | — | ||
| Q2 25 | $-28.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-20.9M | — | ||
| Q1 24 | $-26.0M | — |
| Q4 25 | -1560.0% | — | ||
| Q3 25 | -2340.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -4577.0% | — | ||
| Q1 24 | -4919.5% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 5.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 45.8% | — | ||
| Q1 24 | 2.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
